NL6617379A - - Google Patents

Info

Publication number
NL6617379A
NL6617379A NL6617379A NL6617379A NL6617379A NL 6617379 A NL6617379 A NL 6617379A NL 6617379 A NL6617379 A NL 6617379A NL 6617379 A NL6617379 A NL 6617379A NL 6617379 A NL6617379 A NL 6617379A
Authority
NL
Netherlands
Application number
NL6617379A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6617379A publication Critical patent/NL6617379A/xx
Priority to NL717117150A priority Critical patent/NL152863B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NL6617379A 1965-12-14 1966-12-09 NL6617379A (cg-RX-API-DMAC10.html)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL717117150A NL152863B (nl) 1965-12-14 1971-12-14 Werkwijze voor de bereiding van een glucoside.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH1722965 1965-12-14
CH1723265A CH469000A (de) 1965-12-14 1965-12-14 Verfahren zur Herstellung neuer Glucoside
CH1723065A CH507934A (de) 1965-12-14 1965-12-14 Verfahren zur Herstellung eines neuen Glucosids
CH1470366 1966-10-12

Publications (1)

Publication Number Publication Date
NL6617379A true NL6617379A (cg-RX-API-DMAC10.html) 1967-06-15

Family

ID=27429581

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6617379A NL6617379A (cg-RX-API-DMAC10.html) 1965-12-14 1966-12-09

Country Status (15)

Country Link
AT (2) AT295048B (cg-RX-API-DMAC10.html)
BE (1) BE691066A (cg-RX-API-DMAC10.html)
CH (2) CH507934A (cg-RX-API-DMAC10.html)
DK (2) DK120849B (cg-RX-API-DMAC10.html)
ES (1) ES334424A1 (cg-RX-API-DMAC10.html)
FI (2) FI47357C (cg-RX-API-DMAC10.html)
FR (1) FR6310M (cg-RX-API-DMAC10.html)
GB (1) GB1163106A (cg-RX-API-DMAC10.html)
IL (3) IL27042A (cg-RX-API-DMAC10.html)
NL (1) NL6617379A (cg-RX-API-DMAC10.html)
NO (1) NO120371B (cg-RX-API-DMAC10.html)
OA (1) OA02648A (cg-RX-API-DMAC10.html)
SE (2) SE370072B (cg-RX-API-DMAC10.html)
SU (1) SU414788A3 (cg-RX-API-DMAC10.html)
YU (1) YU33197B (cg-RX-API-DMAC10.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713246A (en) * 1984-03-19 1987-12-15 Bristol-Myers Company Etoposide oral dosage form
US4965348A (en) * 1989-05-19 1990-10-23 Bristol-Myers Company Dimeric epipodophyllotoxin glucoside derivatives
US5036055A (en) * 1989-06-07 1991-07-30 Bristol-Myers Company Acylated derivatives of etoposide

Also Published As

Publication number Publication date
GB1163106A (en) 1969-09-04
CH469000A (de) 1969-02-28
FI47357B (cg-RX-API-DMAC10.html) 1973-07-31
AT298681B (de) 1972-05-25
BE691066A (cg-RX-API-DMAC10.html) 1967-06-12
YU33197B (en) 1976-06-30
FI47358B (cg-RX-API-DMAC10.html) 1973-07-31
FI47357C (fi) 1973-11-12
DK120849B (da) 1971-07-26
IL34853A0 (en) 1970-09-17
CH507934A (de) 1971-05-31
NO120371B (cg-RX-API-DMAC10.html) 1970-10-12
DK118826B (da) 1970-10-12
SE337595B (cg-RX-API-DMAC10.html) 1971-08-16
YU233166A (en) 1975-12-31
AT295048B (de) 1971-12-27
FI47358C (fi) 1973-11-12
ES334424A1 (es) 1968-03-01
IL27042A (en) 1971-04-28
IL34853A (en) 1971-04-28
FR6310M (cg-RX-API-DMAC10.html) 1968-09-16
OA02648A (fr) 1970-12-15
SE370072B (cg-RX-API-DMAC10.html) 1974-09-30
SU414788A3 (cg-RX-API-DMAC10.html) 1974-02-05

Similar Documents

Publication Publication Date Title
FR6310M (cg-RX-API-DMAC10.html)
BE675176A (cg-RX-API-DMAC10.html)
BE674616A (cg-RX-API-DMAC10.html)
BE658570A (cg-RX-API-DMAC10.html)
BE659194A (cg-RX-API-DMAC10.html)
BE660310A (cg-RX-API-DMAC10.html)
BE660801A (cg-RX-API-DMAC10.html)
BE663662A (cg-RX-API-DMAC10.html)
BE665745A (cg-RX-API-DMAC10.html)
BE665895A (cg-RX-API-DMAC10.html)
BE666106A (cg-RX-API-DMAC10.html)
BE666270A (cg-RX-API-DMAC10.html)
BE666799A (cg-RX-API-DMAC10.html)
BE667281A (cg-RX-API-DMAC10.html)
BE667846A (cg-RX-API-DMAC10.html)
BE668430A (cg-RX-API-DMAC10.html)
BE668772A (cg-RX-API-DMAC10.html)
BE669161A (cg-RX-API-DMAC10.html)
BE669488A (cg-RX-API-DMAC10.html)
BE671468A (cg-RX-API-DMAC10.html)
BE672573A (cg-RX-API-DMAC10.html)
BE672914A (cg-RX-API-DMAC10.html)
BE673319A (cg-RX-API-DMAC10.html)
BE673491A (cg-RX-API-DMAC10.html)
BE673583A (cg-RX-API-DMAC10.html)